AAAAAA
Results:
1-13
|
Results: 13
Authors:
Andrey, J
Saven, A
Citation: J. Andrey et A. Saven, Therapeutic advances in the treatment of hairy cell leukemia, LEUK RES, 25(5), 2001, pp. 361-368
Authors:
Saven, A
Citation: A. Saven, Treatment of hairy-cell leukemia, N ENG J MED, 345(20), 2001, pp. 1500-1500
Authors:
Felding-Habermann, B
O'Toole, TE
Smith, JW
Fransvea, E
Ruggeri, ZM
Ginsberg, MH
Hughes, PE
Pampori, N
Shattil, SJ
Saven, A
Mueller, BM
Citation: B. Felding-habermann et al., Integrin activation controls metastasis in human breast cancer, P NAS US, 98(4), 2001, pp. 1853-1858
Authors:
Glaspy, J
Jadeja, JS
Justice, G
Kessler, J
Richards, D
Schwartzberg, L
Rigas, J
Kuter, D
Harmon, D
Prow, D
Demetri, G
Gordon, D
Arseneau, J
Saven, A
Hynes, H
Boccia, R
O'Byrne, J
Colowick, AB
Citation: J. Glaspy et al., A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy, BR J CANC, 84, 2001, pp. 17-23
Authors:
Smith, RE
Jaiyesimi, IA
Meza, LA
Tchekmedyian, N
Chan, D
Griffith, H
Brosman, S
Bukowski, R
Murdock, M
Rarick, M
Saven, A
Colowick, AB
Fleishman, A
Gayko, U
Glaspy, J
Citation: Re. Smith et al., Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer, BR J CANC, 84, 2001, pp. 24-30
Authors:
Tetreault, SA
Saven, A
Citation: Sa. Tetreault et A. Saven, Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenstrom macroglobulinemia, LEUK LYMPH, 37(1-2), 2000, pp. 125-130
Authors:
Duchini, A
Younossi, ZM
Saven, A
Bordin, GM
Knowles, HJ
Pockros, PJ
Citation: A. Duchini et al., An open-label pilot trial of cladibrine (2-chlorodeoxyadenosine) in patients with primary sclerosing cholangitis, J CLIN GAST, 31(4), 2000, pp. 292-296
Authors:
Tetreault, SA
Robbins, BA
Saven, A
Citation: Sa. Tetreault et al., Treatment of hairy cell leukemia-variant with cladribine, LEUK LYMPH, 35(3-4), 1999, pp. 347
Authors:
Piro, LD
White, CA
Grillo-Lopez, AJ
Janakiraman, N
Saven, A
Beck, TM
Varns, C
Shuey, S
Czuczman, M
Lynch, JW
Kolitz, JE
Jain, V
Citation: Ld. Piro et al., Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed orrefractory low-grade or follicular non-Hodgkin's lymphoma, ANN ONCOL, 10(6), 1999, pp. 655-661
Authors:
Saven, A
Burian, C
Adusumalli, J
Koziol, JA
Citation: A. Saven et al., Filgrastim for cladribine-induced neutropenic fever in patients with hairycell leukemia, BLOOD, 93(8), 1999, pp. 2471-2477
Authors:
Saven, A
Burian, C
Citation: A. Saven et C. Burian, Cladribine activity in adult Langerhans-cell histiocytosis, BLOOD, 93(12), 1999, pp. 4125-4130
Authors:
Pauls, JD
Brems, J
Pockros, PJ
Saven, A
Wagner, RL
Weber, R
Metcalfe, D
Christiansen, SC
Citation: Jd. Pauls et al., Mastocytosis - Diverse presentations and outcomes, ARCH IN MED, 159(4), 1999, pp. 401-405
Authors:
Liu, ES
Burian, C
Miller, WE
Saven, A
Citation: Es. Liu et al., Bolus administration of cladribine in the treatment of Waldenstrom macroglobulinaemia, BR J HAEM, 103(3), 1998, pp. 690-695
Risultati:
1-13
|